These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15069567)

  • 1. Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension.
    Akarsu C; Yilmaz S; Taner P; Ergin A
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):814-8. PubMed ID: 15069567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
    Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
    Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428].
    Zeitz O; Matthiessen ET; Reuss J; Wiermann A; Wagenfeld L; Galambos P; Richard G; Klemm M
    BMC Ophthalmol; 2005 Apr; 5():6. PubMed ID: 15811188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost].
    Zeitz O; Matthiessen ET; Wiermann A; Reuss J; Richard G; Klemm M
    Klin Monbl Augenheilkd; 2004 Jul; 221(7):550-4. PubMed ID: 15273908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma.
    Stankiewicz A; Wierzbowska J; Siemiatkowska A; Fuksinska B; Robaszkiewicz J; Zegadlo A; Ehrlich R; Siesky B; Harris A
    Br J Ophthalmol; 2010 Oct; 94(10):1307-11. PubMed ID: 20558428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients.
    Alagoz G; Gürel K; Bayer A; Serin D; Celebi S; Kukner S
    Ophthalmologica; 2008; 222(2):88-95. PubMed ID: 18303228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
    Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Color Doppler imaging and ocular pulse amplitude in glaucomatous and healthy eyes.
    Stalmans I; Harris A; Fieuws S; Zeyen T; Vanbellinghen V; McCranor L; Siesky B
    Eur J Ophthalmol; 2009; 19(4):580-7. PubMed ID: 19551672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study].
    García-Pérez JL; Puerto-Hernández B; Rebolleda Fernández G; Muñoz-Negrete FJ; González-Gordaliza C
    Arch Soc Esp Oftalmol; 2010 Apr; 85(4):131-7. PubMed ID: 20858400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color Doppler imaging in ocular hypertension and open-angle glaucoma.
    Akarsu C; Bilgili MYK
    Graefes Arch Clin Exp Ophthalmol; 2004 Feb; 242(2):125-129. PubMed ID: 14663592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride.
    Stankiewicz A; Misiuk-Hojło M; Grabska-Liberek I; Romanowska-Dixon B; Wierzbowska J; Wasyluk J; Mulak M; Szuścik I; Sierdziński J; Ehrlich R; Siesky B; Harris A
    Acta Ophthalmol; 2011 Feb; 89(1):e57-63. PubMed ID: 21223530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
    Christiansen GA; Nau CB; McLaren JW; Johnson DH
    Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination.
    Day DG; Sharpe ED; Beischel CJ; Jenkins JN; Stewart JA; Stewart WC
    Eur J Ophthalmol; 2005; 15(3):336-42. PubMed ID: 15945001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
    Coleman AL; Lerner F; Bernstein P; Whitcup SM
    Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effect of latanoprost on ocular circulation in ocular hypertension.
    Akarsu C; Bilgili YK; Taner P; Unal B; Ergin A
    Clin Exp Ophthalmol; 2004 Aug; 32(4):373-7. PubMed ID: 15281970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting.
    Park KH; Simonyi S; Kim CY; Sohn YH; Kook MS
    BMC Ophthalmol; 2014 Dec; 14():160. PubMed ID: 25519810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.